Purchase Order 75N98F18P00020

<p>The National Institute of Nursing Research awarded a purchase order to Partek, Incorporated for $7,800.00 on July 14, 2017. Performance is in Albuquerque, New Mexico, with an ultimate completion date of August 15, 2017. The order is a firm fixed-price acquisition for bioinformatics software solutions. No set-aside was applied.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Partek, Incorporated for $22,550.00 on August 26, 2019, with an ultimate completion date of August 25, 2020. The order was firm fixed price with no set-aside. Place of performance is Wildwood, Missouri. The purchase order procures bioinformatics software for genomic analysis and research support.</p>

The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to Partek, Incorporated for $16,290.00 on March 16, 2021, with an ultimate completion date of March 31, 2021. No set-aside applied. Place of performance is Wildwood, Missouri. The order procures Partek Flow, a bioinformatics analysis software platform for processing next-generation sequencing data from multiple research projects at NIAMS. The software has demonstrated measurable increases in...

<p>The National Institute of Nursing Research awarded a purchase order to Noldus Information Technology, Inc. for $8,067.00 on June 5, 2018, with final completion by July 5, 2018. Performance is based in Leesburg, Virginia. The firm fixed price order procures observational research tools and behavioral analysis software from the vendor's product portfolio, which includes video tracking systems and automated monitoring equipment for research applications.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Partek, Incorporated for $9,330.00 on May 2, 2018, with completion targeted for June 1, 2019. No set-aside applies. Performance occurs in Bethesda, Maryland. The order procures bioinformatics software solutions, specifically genomic analysis and visualization tools for federal research. Pricing is firm fixed price.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Partek, Incorporated for $13,212.00 on August 24, 2018, with ultimate completion on August 28, 2018. The contract is firm fixed-price with no set-aside designation. Performance occurs in Bethesda, Maryland. The order procures bioinformatics software solutions, specifically genomic analysis tools from Partek's product suite for research support.</p>

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to Partek, Incorporated for $17,000 on November 3, 2020, for a 12-month software license renewal. The order, priced on a firm fixed-price basis, supports single-cell transcriptomics, cell-type identification and discovery, and next-generation sequencing applications. Performance is located in Wildwood, Missouri. The order completed on November 3, 2020.</p>

<p>The National Institutes of Health Office of Logistics and Acquisition Operations awarded a purchase order to Partek, Incorporated for three Partek Genomics Suite floating concurrent subscriptions valued at $357,883.00 on September 17, 2015. Place of performance is Wildwood, Missouri. The order is a firm fixed-price arrangement with no set-aside designation. The period of performance ran from September 21, 2020 through March 20, 2021, covering a six-month extension.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Partek, Incorporated valued at $16,494.00 on August 23, 2019. Performance is located in Bethesda, Maryland. The order is for bioinformatics software solutions, specifically Partek's genomic analysis platforms designed to support advanced genomic research and data analysis. The purchase order is firm fixed-price with an ultimate completion date of September 30, 2020. No small business set-aside was applied.</p>

<p>The National Institute of Nursing Research awarded a purchase order to the National Academy of Sciences for $5,996.36 on April 6, 2020, with final completion by April 30, 2021. Performance will take place in Washington, DC. The order is firm fixed price with no set-aside designation.</p>